TAZ has been implicated in promoting liver fibrosis, particularly in the steatosis-to-NASH conversion via the induction of IHH in hepatocytes, a secretory factor that activates HSCs 21. This evidence concerns the gene IHH and metabolic dysfunction-associated steatohepatitis.